CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

National Foot Care Program

National Foot Care Program is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Beacon Specialized Living

Beacon Specialized Living is a company that provides assisted living facilities and behavioral healthcare services for developmentally disabled, mentally ill, and autistic adults.

Osceola Regional Medical Center

Osceola Regional Medical Center is a Kissimmee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Moonlighting Solutions

Moonlighting Solutions is a physician-owned and operated company that provides hospitals with short and long-term physician coverage, specializing in night and weekend call coverage. They also offer permanent placement opportunities for their moonlight...

Nanobiotix

Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is one rooted in designing pioneer physical based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges.